Potassium salt with ACE inhibitor and MRA — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Potassium salts with ramipril and spironolactone increase hyperkalaemia risk
ACE inhibitors and spironolactone both increase serum potassium. Adding potassium salts in a patient with CKD and existing borderline hyperkalaemia could be dangerous. The urinary symptoms also need assessment for infection or other causes rather than routine alkalinisation.
Reference: BNF